tetano
Editor, Senior Moderator
SAGE Open Med
. 2022 Jul 6;10:20503121221108616.
doi: 10.1177/20503121221108616. eCollection 2022.
COVID-19 vaccine side effect: age and gender disparity in adverse effects following the first dose of AstraZeneca COVID-19 vaccine among the vaccinated population in Eastern Ethiopia: a community-based study
Astawus Alemayehu[SUP] 1 2 [/SUP], Abebaw Demissie[SUP] 1 3 [/SUP], Mohammed Yusuf[SUP] 1 4 [/SUP], Yasin Abdullahi[SUP] 5 [/SUP], Remzia Abdulwehab[SUP] 2 [/SUP], Lemessa Oljira[SUP] 6 [/SUP], Dereje Feleke[SUP] 7 [/SUP]
Affiliations
Abstract
Objective: The pandemic of coronavirus disease 2019 (COVID-19) is a major threat to community health, and vaccinations are a safe and effective way to reduce disease loads around the world. This study aimed to assess the age and gender disparity in adverse effects following the first dose of the AstraZeneca COVID-19 vaccine among the vaccinated population in Eastern Ethiopia.
Methods: A community-based cross-sectional study design was conducted among 832 randomly selected individuals from December 1st to 20th, 2021, in eastern Ethiopia. Data were collected by face-to-face interviews using a pretested structured questionnaire. Data were analyzed using the SPSS V26. Descriptive summary statistics were done. A chi-square test statistic was computed to assess the difference in adverse effects between age groups and both genders.
Result: Out of 832 study participants who had taken the first dose of AstraZeneca vaccine, 96.3% of them felt at least one adverse effect. The magnitude of adverse reactions was higher among male participants. The reported adverse reactions were significantly higher in the age group of 50-60 years with comorbidity than those of <50 and >60 years of age.
Conclusion: Overall, there is a significant age and gender difference in adverse effects following the first dose of the AstraZeneca COVID-19 vaccine. In addition, adverse reactions were higher among people with comorbidity in the age group of 50-60 years. The Harari Regional Health Bureau should provide training for frontline healthcare workers on early recognition and response to adverse effects of the COVID-19 vaccine. In addition, information and education should be provided to the community as a whole regarding recognition and the appropriate measures to be taken.
Keywords: COVID-19 vaccine; adverse effects; age disparity; gender disparity.
. 2022 Jul 6;10:20503121221108616.
doi: 10.1177/20503121221108616. eCollection 2022.
COVID-19 vaccine side effect: age and gender disparity in adverse effects following the first dose of AstraZeneca COVID-19 vaccine among the vaccinated population in Eastern Ethiopia: a community-based study
Astawus Alemayehu[SUP] 1 2 [/SUP], Abebaw Demissie[SUP] 1 3 [/SUP], Mohammed Yusuf[SUP] 1 4 [/SUP], Yasin Abdullahi[SUP] 5 [/SUP], Remzia Abdulwehab[SUP] 2 [/SUP], Lemessa Oljira[SUP] 6 [/SUP], Dereje Feleke[SUP] 7 [/SUP]
Affiliations
- PMID: 35832260
- PMCID: PMC9272167
- DOI: 10.1177/20503121221108616
Abstract
Objective: The pandemic of coronavirus disease 2019 (COVID-19) is a major threat to community health, and vaccinations are a safe and effective way to reduce disease loads around the world. This study aimed to assess the age and gender disparity in adverse effects following the first dose of the AstraZeneca COVID-19 vaccine among the vaccinated population in Eastern Ethiopia.
Methods: A community-based cross-sectional study design was conducted among 832 randomly selected individuals from December 1st to 20th, 2021, in eastern Ethiopia. Data were collected by face-to-face interviews using a pretested structured questionnaire. Data were analyzed using the SPSS V26. Descriptive summary statistics were done. A chi-square test statistic was computed to assess the difference in adverse effects between age groups and both genders.
Result: Out of 832 study participants who had taken the first dose of AstraZeneca vaccine, 96.3% of them felt at least one adverse effect. The magnitude of adverse reactions was higher among male participants. The reported adverse reactions were significantly higher in the age group of 50-60 years with comorbidity than those of <50 and >60 years of age.
Conclusion: Overall, there is a significant age and gender difference in adverse effects following the first dose of the AstraZeneca COVID-19 vaccine. In addition, adverse reactions were higher among people with comorbidity in the age group of 50-60 years. The Harari Regional Health Bureau should provide training for frontline healthcare workers on early recognition and response to adverse effects of the COVID-19 vaccine. In addition, information and education should be provided to the community as a whole regarding recognition and the appropriate measures to be taken.
Keywords: COVID-19 vaccine; adverse effects; age disparity; gender disparity.